SEC Form 4 · accession 0001140361-17-015451
Bath & Body Works, Inc. · BBWI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Leslie H. Wexner
Officer — Chairman and CEO · Director · 10% Owner
Abigail S Wexner
Director
Period of report
Apr 6, 2017
Accepted (ET)
Apr 10, 2017 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000701985
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3,F4 | Apr 6, 2017 | M | 238,951 | $12.0776 | A | 16,698,975 | D | |
| Common StockF2,F3,F4 | Apr 6, 2017 | M | 384,567 | $6.1448 | A | 17,083,542 | D | |
| Common StockF2,F3,F4 | Apr 6, 2017 | M | 127,639 | $18.088 | A | 17,211,181 | D | |
| Common StockF2,F3,F4 | Apr 6, 2017 | M | 305,224 | $23.6382 | A | 17,516,405 | D | |
| Common StockF2,F3,F4 | Apr 6, 2017 | M | 87,361 | $26.4271 | A | 17,603,766 | D | |
| Common StockF2,F3,F4 | Apr 6, 2017 | M | 202,039 | $35.7103 | A | 17,805,805 | D | |
| Common StockF2,F3,F4 | Apr 6, 2017 | M | 55,572 | $41.5439 | A | 17,861,377 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F5,F6,F13,F2,F3 | $12.0776 | Apr 6, 2017 | M | 238,951 | D | — | Mar 31, 2018 | Common Stock | 238,951 | 0 | D |
| Stock option (right to buy)F5,F7,F13,F2,F3,F6 | $6.1448 | Apr 6, 2017 | M | 384,567 | D | — | Mar 31, 2019 | Common Stock | 384,567 | 0 | D |
| Stock option (right to buy)F5,F8,F13,F2,F3,F6 | $18.088 | Apr 6, 2017 | M | 127,639 | D | — | Mar 31, 2020 | Common Stock | 127,639 | 0 | D |
| Stock option (right to buy)F5,F9,F13,F2,F3,F6 | $23.6382 | Apr 6, 2017 | M | 305,224 | D | — | Jan 27, 2021 | Common Stock | 305,224 | 0 | D |
| Stock option (right to buy)F5,F10,F13,F2,F3,F6 | $26.4271 | Apr 6, 2017 | M | 87,631 | D | — | Mar 31, 2021 | Common Stock | 87,631 | 0 | D |
| Stock option (right to buy)F5,F11,F13,F2,F3,F6 | $35.7103 | Apr 6, 2017 | M | 202,039 | D | — | Jan 26, 2022 | Common Stock | 202,039 | 0 | D |
| Stock option (right to buy)F5,F12,F13,F2,F3,F6 | $41.5439 | Apr 6, 2017 | M | 55,572 | D | — | Mar 30, 2022 | Common Stock | 55,572 | 0 | D |
Explanation of responses
- F1Stock option exercised by Leslie H. Wexner ("Mr. Wexner").
- F10The Issuer originally granted 72,178 stock options to Mr. Wexner with an exercise price of $31.9875 per share pursuant to the Issuer's stock plan. The options vested in original installments as follows: 3/31/12 - 24,059 shares; 3/31/13 - 24,059 shares; and 3/31/14 - 24,060 shares.
- F11The Issuer originally granted 174,867 stock options to Mr. Wexner with an exercise price of $41.26 per share pursuant to the Issuer's stock plan. The options vested in original installments as follows: 1/26/14 - 34,974 shares; 1/26/15 - 34,973 shares; 1/26/16 - 52,460; and 1/26/17 - 52,460 shares.
- F12The Issuer originally granted 48,100 stock options to Mr. Wexner with an exercise price of $48 per share pursuant to the Issuer's stock plan. The options vested in original installments as follows: 3/30/14 - 9,620 shares; 3/30/15 - 9,620 shares; 3/30/16 - 14,430; and 3/30/17 - 14,430 shares.
- F13Not applicable.
- F2Owned by Mr. Wexner directly. Owned by Abigail S. Wexner ("Mrs. Wexner") indirectly, through Mr. Wexner.
- F3Mr. Wexner and Mrs. Wexner disclaim beneficial ownership of all indirectly owned securities reported on this Form in excess of their respective pecuniary interests therein.
- F4See Exhibit 99.1 for a table of all non-derivative shares of the Issuer beneficially owned directly or indirectly by Mr. Wexner and Mrs. Wexner.
- F5Reflects adjustments from antidilution etc. pursuant to the Issuer's stock plan.
- F6The Issuer originally granted 168,772 stock options to Mr. Wexner with an exercise price of $17.10 per share pursuant to the Issuer's stock plan. The options vested in original installments as follows: 3/31/09 - 42,193 shares; 3/31/10 - 42,193 shares; 3/31/11 - 42,193 shares; and 3/31/12 - 42,193 shares.
- F7The Issuer originally granted 271,620 stock options to Mr. Wexner with an exercise price of $8.70 per share pursuant to the Issuer's stock plan. The options vested in original installments as follows: 3/31/10 - 90,540 shares; 3/31/11 - 90,540 shares; and 3/31/12 - 90,540 shares.
- F8The Issuer originally granted 93,777 stock options to Mr. Wexner with an exercise price of $24.62 per share pursuant to the Issuer's stock plan. The options vested in original installments as follows: 3/31/11 - 31,259 shares; 3/31/12 - 31,259 shares; and 3/31/13 - 31,259 shares.
- F9The Issuer originally granted 245,325 stock options to Mr. Wexner with an exercise price of $29.41 per share pursuant to the Issuer's stock plan. The options vested in original installments as follows: 1/27/13 - 49,065 shares; 1/27/14 - 49,065 shares; 1/27/15 - 73,598 shares; and 1/27/16 - 73,597 shares.
Remarks
Exhibit 99.1: Additional Responses and Joint Filer Information, incorporated herein by reference.